US Patent 10081624 Heterocyclic compound
Patent 10081624 was granted and assigned to Takeda Pharmaceutical Company on September, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 25, 2015
Date of Patent
September 25, 2018
Patent Application Number
15506380
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10081624 Heterocyclic compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
